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Antibodies binding to a variety of self antigens have been found in the sera of
normal individuals (1). Autoantibodies have been identified that bind to nuclear
antigens (DNA, RNA, histories), to cellular antigens, to cell-surface membrane
molecules, and to serum proteins (2-6). Cells producing such autoantibodies
have been cloned as murine hybridomas from fetal, newborn, and adult normal
mice (2-4, 7) and as EBV-transformed B cells or as hybridomas from normal
human individuals (4, 5, 8, 9). These findings have implied that the normal
repertoire of the immune system includes self antigen-binding B cells.
Autoantibodies binding to self antigen have also been found in a variety of
autoimmune disorders, among them chronic GVHD (reviewed in reference 10).
This disease in mice closely resembles SLE in man. Autoantibodies to nuclear
antigens (ANA),' to thymocytes, and to erythrocytes are found in the serum.
Immune complex glomerulonephritis (ICGN) develops in later stages of the
disease (10, 11). Chronic GVHD can be induced in normal, not genetically
autoimmune disease-prone F1 mice by injection of Th cells of one parent, i.e.,
of alloreactive cells (10, 12-14).
Qualitatively, therefore, the reactivity pattern of B cells appears to be similar
in normal and in GVHD mice in that it contains autoantibody-producing cells.
In this paper we present a quantitative analysis ofthe frequencies of autoantibody-
producing B cells in GVHD and in normal mice. We generate collections of
hybridomas that allow the production ofsufficient quantitiesof secreted antibody
needed for these analyses. B cells have to be activated before they will fuse with
the Sp 2/0 line to generate hybridomas (15). We use a variety of procedures to
activate splenic B cells in vivo and in vitro. We activate (C57BL/6J x DBA/2)F 1
B cells in vivo by injection of alloreactive Th cells of one parent (GVHD), by a
foreign antigen in a secondary response (SRBC), or by LPS as a polyclonal
activator. We also use B cells in experimentally unstimulated animals that are
activated by the normal background. Finally we activate B cells in vitro by LPS
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and by alloreactive T cells. The quality of the response is monitored by the fine
specificity and the class of antibody produced .
Materials and Methods
Mice.
￿
Female (C57BL/6J X DBA/2)F, and DBA/2 mice, as well as Lewis rats, 6-10
wk old, were obtained from the Institut fur Biologisch-Medizinische Forschung, AG .,
Fullinsdorf, Switzerland .
Immunizations .
￿
Graft-vs.-host reaction (GVHR) was induced in female (C57BL/6J X
DBA/2)F, mice by intravenous injection of 2 X 10' nylon wool-purified splenic T cells
(16) of female DBA/2 mice . Fusion of the spleen cells of individual mice was performed
at different times after the induction of the GVHR as indicated in the results . In vivo
activation of spleen cells with LPS was performed by injecting (C57BL/6J X DBA/2)F,
mice intravenously with 100 ug LPS (S-form ofSalmonella abortus equii, a kind gift of Drs .
C . Galanos and O . Ldderitz, Max Planck Institut fur Immunbiologie, Freiburg, Federal
Republic of Germany) . Fusions were performed 3 days after the injection of LPS . A
secondarySRBC response was induced in (C57BL/6JX DBA/2)F, mice by two intravenous
injections of 108 SRBC on day 0 and day 14 . Fusion of the spleen cells of these mice was
done on day 19 .
Cell Cultures .
￿
Stimulation of spleen cells in vitro was done in several ways . (C57BL/6J
X DBA/2)F, spleen cells at a concentration of 106 cells/ml, were stimulated by coculture
with 2 X 10 5 irradiated (1,500 rad) alloreactive C57BL/6 anti-BALB/c Th cells per
milliliter . Fusion was performed at day 3 of culture . LPS stimulation of (C57BL/6J X
DBA/2)F, spleen cells in vitro was performed at a concentration of 5 X 10 5 spleen cells
per milliliter in the presence o£ 50 ug/ml of LPS . Fusion was performed at day 5 of
culture . (C57BL/6J X DBA/2)F, fetal liver cells taken at day 17 of gestation were
stimulated at a concentration of 108 cells per milliliter with 50 t+g/ml of LPS . Fusion was
performed at day 7 of culture . All above-mentioned cultures were performed in serum-
substituted culture medium (17) .
Fibroblasts LtK- used for indirect immunofluorescence were grown overnight onto
eight-hole microscope slides (Cell-Line Associates, Newfield, NY) in RPMI 1640 medium
containing 10% FCS .
Production of mAbs.
￿
In vivo or in vitro-stimulated (C57BL/6J X DBA/2)F, spleen or
fetal liver cells were fused with the nonsecreting, azaguanine-resistant hybridoma cell line
SP 2/0 according to the original protocol of Kohler and Milstein (18) . The fused cells
were plated into microtiter plates under limiting dilution conditions in the presence of rat
thymocytes (3 X 106/ml) as filler cells (19) . Autoantibody production was measured from
those cultures that showed positive growth and, according to Poisson's distribution, had
a >98% probability of being derived from a single fusion event, i.e ., a hybridoma clone .
Assays.
￿
Thenumber of IgM- and IgG-secreting cells was determined using the protein
A plaque assay as originally described by Gronowicz et al . (20) . The presence of autoanti-
bodies to thymocytes and nuclear antigens in the serum was determined as described (12-
14) . Whether mice had ICGN was determined with direct immunofluorescence as previ-
ously described (11) . Cryostat sections (4 um) of mouse kidney, liver, stomach, lung, and
intestine, as well as human kidney, liver, esophagus, and small intestine used for indirect
immunofluorescence tests were fixed in acetone for 10 min and then air dried . Fibroblasts
used for indirect immunofluorescence were fixed for 15 min in ethanol containing 5%
acetic acid at -20 °C . Cells were rehydrated in PBS .
Indirect immunofluorescence on sections or fibroblasts was done by incubating these
for 30 min with hybridoma culture supernatant. Thereafter they were washed with PBS
for 30 min and then incubated with FITC-labeled goat anti-mouse IgM + IgG Qackson
Research Laboratory, Avondale, PA) diluted 1 :20 in PBS . After extensive washing with
PBS the slides were read in an Orthoplan microscope (E . Leitz, Wetzlar, Federal Republic
of Germany) with incident illumination .
Anti-DNA antibodies were determined as described by Smeenk (21) . Briefly, Elisa
plates were precoated with a 0 .05% (W/V) solution of protamin sulfate and then coatedROLINK ET AL .
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overnight at 4°C with native salmon sperm DNA at a concentration of 6,ug/ml . Hybri-
doma culture supernatants to be tested forbinding were diluted 1 in 1 with PBS containing
0.1% Tween-20 and2% BSA . A one in 1000 diluted alkaline phosphatase labelled goat-
anti-mouse IgM + IgG (Jackson Research Laboratory) wasused as conjugate . Binding was
assayedby the presence of enzymatic activity usingp-nitrophenylphosphate asasubstrate .
Ig Class and Subclass Determination.
￿
The Ig (sub)classes produced by the hybridomas
were determined in an ELISA . ELISA plates (Dynatech, Plochingen, Federal Republic of
Germany) were coated with 10 ag/ml affinity-purified goat anti-mouse IgM + IgG
(Jackson Immuno Research, Avondale, PA) for 2 h at room temperature . After extensive
washingof the plates with PBS, 50 I,1of culture supernatant, diluted 1 :1 in PBS containing
0.2% Tween 20, was applied to the wells for a period of 2 h. Thereafter, the plates were
washed five times with PBS and incubated with 50 ul of 1 :500 diluted (PBS + 0.2%
Tween 20) alkaline phosphatase-labeled goat anti-mouse Ig, IgM, IgGI, IgG2a, IgG2b,
IgG3 (lc or A) (all purchased from Southern Biotechnology Associates, Inc., Birmingham,
AL), for 2 h. After extensive washing with PBS, 200 1A1 of the substrate p-nitrophenyl
phosphate (1 mg/ml) was added . After a 30-min incubation period the plates were read
in a Titertek ELISA reader (Flow Laboratories, Rickmansworth, United Kingdom) at
405nm .
Results
In Vivo Activation and Autoimmune Response of(C57BL/6f X DBA/2)F1 Splenic
B Cells by Injection ofDBA/2 T Cells. It is known that injection ofDBA/2 T cells
into adult (C57BL/6j X DBA/2)F 1 mice can lead to chronicGVHD that closely
resembles SLE (10) . Therefore, we monitored in such mice the total activation
of the B cell compartment in the spleen to Ig-secreting cells, the formation of
ANAs and autoantibodies to thymocytes, and the development of ICGN with
time after injection of the T cells . Normal mice that were not injected with T
cells were used as controls. The results summarized in Table I show activation
to IgM- and IgG-secreting cells within amaximum of 2 wk afterT cell injection .
Numbers of IgM-secreting cells returned to normal levels at 5-8 wk afterT cell
injection .
The levels of IgG-secreting cells at 2 wk after T cell injection are 10 times
higher than those ofIgM-secreting cells and 50 timeshigher than the background
in unstimulated mice . Furthermore, they remain elevated at least five times
above the normal background even 8 wk after theT cell injection . The mice
have autoantibodies against thymocytes in their serum as early as 1 wk after T
cell injection and up to 8 wk afterward . ANAs could not be detected at 1 wk,
but later on they were detected throughout .
Mice at various times after T cell injection served as a source for activated
spleen cells, which were used in fusions with the azaguanine-resistant SP 2/0
hybridoma cell line to develop repertoires of hybridomas . One mouse used for
fusion at 5 wk after T cell injection and the two mice used for fusion at 8 wk
had developed ICGN . This is a sign that the mice used in the present study
indeed developed SLE-like GVHD.
Frequencies of Autoantibody-secreting Hybridomas Obtainedfrom Spleen Cells of
(C57BL/6J X DBA/2)F1 Mice Stimulated in Various Ways. Repertoires of hybri-
domas were prepared by fusing spleen cells from (C57BL/6J X DBA/2)F1 mice
activated in different ways. In vivo they were stimulated by parental DBA/2 T
cells, i.e ., by alloreactive cells, which could induce GVHD . Spleen cells were
fused before as well as after the manifestation of the disease, i.e ., at 1, 2, 5, and1678
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Time
TABLE I
Activation and Autoimmune Reactions ofSplenicB Cells of
(C57BL/6J x DBA/2)F, Mice Injected withDBA/2SplenicT Cells
Ig-producing cells per 106 ￿Autoantibodiesin serum
* At these various times spleen cells of these mice were prepared and fused with the Sp2/0 line to
obtain the hybridoma described in the following results .
$ +, detectable in assays described in the Materials and Methods ; -, not detectable .
4 Normal mice not injected with T cells were used as controls.
8 wk . Other mice were stimulated in vivo with the polyclonal activator LPS, or
in a secondary response with the antigen SRBC . In vitro spleen cells were
stimulated either with alloreactive Th cells, or with LPS. Finally, hybridoma
repertoires were also made from unstimulated adult spleen cells, and from fetal
liver cells stimulated in vitro with LPS .
Successful fusion events were plated under conditions of limiting dilution .
Only those hybridomas were collected and screened that, according to Poisson's
distribution, had a>98% probability of being derived from a single fusion event.
Frequencies for successful fusion events differed for the spleen cell prepara-
tions from mice activated in different ways . It was one in 2 X 107 for normal
spleen cells, one in 5 X 105 formice injected with either SRBC or with alloreactive
T cells (GVHD mice) and one in 2 X 105 for mice injected with LPS . This
reflects the total status of activation of the B cell compartments in spleen and
suggests, as previously shown with in vitro- and in vivo-activated spleen cells
(15), that activated but not resting cells are the main fusion partners in the
generation of hybridomas .
The antibodies produced by these hybridoma collections were screened for
their capacity to bind to (C57BL/6Jx DBA/2)F I kidney cryosections or toDNA.
Table II summarizes these analyses. Hybridomas producing autoantibodies were
found in all groups . Their frequencies among all hybridomas ranged from 7 .1
(GVHD at 2 wk) to 17 .1% (LPS in vivo) ; within the GVHD mice this frequency
varied from 7 .1% to 11.6% . None of the 47 anti-SRBC mAbs crossreacted with
the tested self antigens . Data in Table II indicate that the frequencies of
hybridomas producing autoantibodies binding to kidney or to DNA are not
Animal
number
after in-
jection of
T cells*
wk
spleen cells
Igm
at time of fusion
IgG
at time
ANA
of fusion$
Antithymo-
cyte
ICGN$
11 0 420 397 - - -
21 0 390 500 - - -
31 0 380 520 - - -
4 1 860 3,400 - + -
5 1 850 3,660 - + -
6 2 2,910 24,930 ++ ++ -
7 2 2,300 23,080 ++ ++ -
8 5 330 2,300 ++ ++ -
9 5 370 4,780 ++ ++ -
10 5 370 13,010 ++ ++ +
11 8 400 4,830 ++ ++ +
12 8 230 2,260 ++ ++ ++ROLINK ET AL .
TABLE Il
Frequencies ofAutoantibody-producing B Cell Hybridomas Derived in
Fusion with Unstimulated Fetal Liver andSpleen Cells, and with Spleen
Cells Stimulated by Various In Vivo and In Vitro Procedures
* For details see Materialsand Methodsand text . Within one group several mice
were fused in individual fusion experiments . Since no differences could be
found in the repertoires of these individual mice, data in the table arepooled
from several fusion experiments.
$ Number of hybridomas producing autoantibodies that bind to kidney section
and/or DNA .
47 of these hybridomas produced SRBC-specific antibodies and none of them
crossreacted with the self antigens tested .
DNA binding was not tested in this group .
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significantly different between those derived from GVHD mice and those from
mice of the same strain activated in different ways . Moreover, the frequencies of
hybridomas producing these autoantibodies does not change with time after
injection of the T cells. This suggests that the development of ICGN at later
times after induction is not simply due to an increased number of activated
splenic B cells producing these autoantibodies .
Different Cellular Specificities of Autoantibodies Detected by Binding to Kidney
Sections. Igs produced by the hybridomas were initially screened for their
capacity to bind to kidney cryosections . The ones found positive were then
screened for binding to different organs of mice and humans, and to murine
fibroblasts. Different staining patterns were found that allowed us to form five
groups of autoantibody-producing hybridomas according to the binding of the
antibodies to different cell structures (Fig. 1) . A strong staining of the brush
border of the proximal tubules of kidneys was seen with antibodies that were
restricted to hybridomas obtained by fusion with GVHD spleen cells, whereas
other organs and fibroblasts were not stained . Antibodies that stained a web in
the cytoplasm of fibroblasts in a fine or coarse network-like pattern could be
directed against cytoskeleton proteins . In frozen sections we observed a staining
of connective tissue cells, like kidney, mesangial cells, and sometimes of smooth
muscle cells and nerve sheaths . In addition, a few antibodies showed a bright
staining of epithelial cells, e.g ., squamous cells, but staining was virtually negative
on connective tissue cells and fibroblasts . They could be directed against keratin
or prekeratin proteins . In all groups, antibodies could be found that stained
Group* Number of
hybridomas
Number of hybri-
domasproducing
tested autoanti-
bodies$
Percentage
Unstimulated spleen cells 112 18 16.1
LPS-stimulated fetal liver cells 236 28 11.9
SRBC 2114 23 10.9
T cell induced in vitro 184 16 8.7
LPS in vivo 181 31 17 .1
LPS in vitro 324 22 1 6.8 1
GVH (1 wk) 22 2 9.1
GVH (2 wk) 311 22 7.1
GVH (5 wk) 129 15 11.6
GVH (8 wk) 122 11 9.01680
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FIGURE 1 .
￿
Indirect immunofluorescence test on frozen sections of murine kidneys, stomach
and on cultured fibroblasts . (A) Autoantibody directed against the brush border area of the
proximal tubuli of the kidney . X 680 . (B) Autoantibody directed against mitochondria.
Granular staining of the cytoplasm of kidney tubuli . X 680 . (C) Autoantibody directed against
cytoskeleton tested on cultured fibroblasts . X 855 . (D) Autoantibody directed against smooth
muscle cells tested on astomach wall. X 210 .TABLE III
BindingofMonoclonal Autoantibodies to Different Cellular Structures
ROLINK ET AL .
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* For details see Materialsand Methods and the text .
Binding tested by immunofluorescence .
smooth muscle cells of vessels, intestine, stomach, and esophagus, as well as
antibodies that appeared directed against nuclei and/or nucleoli . Six antibodies
showed a strong web-like staining of all cells and, in particular, of their nuclei
and/or nucleoli .
Antibodies grouped in the antimitochondrial pattern stained predominantly
total epithelial cells of kidney tubules in a granular pattern and, to a lesser extent,
liver and stomach epithelial cells.
Asummary of these results is given in Table III . As shown, autoantibodies to
cytoskeletal structures are most predominant in almost all groups, being most
frequent in hybridoma collections of fetal liver cells and of normal spleen cells .
We do not consider the differences in frequencies of specificities in the different
hybridoma collections to the different self antigens to be significant . On the
other hand, autoantibodies with specificities for proximal tubular brush border
were only found within the set of GVHD-derived hybridoma . Six GVHD mice
produced such antibodies. It remains to be determined with a wider spectrum of
autoantigens, whether other autoantigens exist to which autoantibodies are only
made inGVHD mice .
A majority, i.e ., 22 out of 28 DNA binding antibodies, were found also to
bind to other cell structures (Table IV). 11 of these antibodies bind to nuclei,
and another 11 to cytoskeletal structures .
Ig (Sub)classes ofthe Monoclonal Autoantibodies.
￿
The class or subclass of Ig with
binding specificities for autoantigens derived from the differently activated B
cell populations was determined by an ELISA described in the Materials and
Methods section . In fact, included in this class and subclass determination were
the Ig molecules produced by all the hybridomas of the differently activated B
cells, regardless of whether they were found to be binding to a self antigen or
not .
Practically all of the monoclonal autoantibodies were derivedfrom nonautoim-
Group*
Number
of hybri-
domas
Brush
border
Autoantibodies
Cyto- Smooth
skeleton muscle
directed
Nuclei
against :
Mito-
chon-
dria
Unde-
fined
Unstimulated spleen 112 - 10 1 2 1 4
cells
LPS-stimulated fetal 236 - 17 3 5 2 1
liver cells
SRBC in vivo 221 - 10 4 5 3 1
Tcell induced in vitro 184 - 6 4 3 1 0
LPS in vivo 181 - 7 8 7 2 4
LPS in vitro 324 - 6 3 7 3 3
GVH (1 wk) 22 - - 1 1 - -
GVH (2 wk) 311 2 8 2 7 1 1
GVH (5 wk) 129 5 5 - 2 2 1
GVH (8 wk) 122 2 6 - 1 - 21682 AUTOANTIBODY REPERTOIRE IN GRAFT-VERSUS-HOST MICE
TABLE IV
DNA-bindingMonoclonal Autoantibodies and their Crossreactivity with Different Cellular
Structures
* For details see Material and Methods .
Number
￿
Immunofluorescence of autoanti-
TABLE V
IgM/IgG Class Distribution in Hybridomas Derivedfrom Spleen Cells Activated by Different
Procedures andfrom Fetal Liver
mune mice, i.e ., F, mice not injected with parental T cells are of the IgM isotype
(Table V) . This finding is not surprising for hybridomas made with polyclonally
stimulated B cells (LPS- and Th cell-induced), since >90% of these hybridomas
produce IgM antibodies (Table V) .
However, 30% of the hybridomas derived from normal mice and 49% (42%
after subtraction of hybridomas producing anti-SRBC antibodies) of the hybri-
domas of mice twice injected with SRBC produce IgG antibodies . Nevertheless,
none of these IgG monoclonal antibodies bound to kidney cryosections, nor to
DNA (Table V) . This indicates thatundernormal conditions autoantigen-binding
B cells can only be stimulated to IgM, but not to IgG secretion .
In marked contrast, many (between 42%-90%) of the GVHD-derived hybri-
Group*
Number of
hybri-
domas
ofDNA-
binding
monoclo-
nal auto-
antibodies
bodies with
Nuclei
DNAbinding capacity
Cytoskel- No immu-
nofluores- eton cence
Unstimulated spleen cells 60 1 1 - -
LPS-stimulated fetal liver cells 236 1 1 - -
SRBC in vivo 211 1 - 1 -
T cell induced in vitro 184 7 1 4 2
LPS in vivo 181 4 1 - 3
GVH (1 wk) 22 - - - -
GVH (2 wk) 311 10 6 3 1
GVH (5 wk) 129 2 1 1 -
GVH (8 wk) 75 2 - 2 -
Group
Total hybridomas produc-
ing :
IgM IgG
Autoantibody-secreting hybri-
domas producing :
IgM IgG
% %
Unstimulated spleen cells 69.6 30.4 100 0
LPS-stimulated fetal liver cells 88.5 11 .5 100 0
SRBC in vivo 51 .2 48.8 100 0
T cell induced in vitro 98.5 1 .5 100 0
LPS in vivo 89.4 10.6 100 0
LPS in vitro 99.2 0.8 100 0
GVH (1 wk) 36.4 63.6 0 100
GVH (2 wk) 10.3 89.7 9.1 90.9
GVH (5 wk) 24.0 76.0 13.3 86.7
GVH (8 wk) 58.2 41 .8 18.2 81 .8ROLINK ET AL .
￿
1683
TABLE VI
Heavy Chain Isotypes ofmAbs with SelfAntigen-binding Specificities
domas produce IgG antibodies and considerably fewer IgM . The relative fre-
quencies ofIgM- and IgG-producing hybridomas changed with time after injec-
tion of the parental T cells, i.e ., with propagation of the GVHD-effect (Table
V), in agreement with the differently changing levels of IgM- and IgGsecreting
cells found in the spleen (Table 1) . Furthermore, as shown in Table V, 80-90%
of the monoclonal autoantibodies are of the IgG class and only 10-20% are of
the IgM class. The y2a isotype is most predominantly used (46%) in the sum of
all GVHD hybridomas, followed by y, (29%) and y2b (12%) (Table VI) . The 73
isotype appears to be rare within autoantibodies of the hybridoma collections
derived from the GVHD mice . All but one of the GVHD-derived monoclonal
autoantibodies use x light chains .
Discussion
For an evaluation of the repertoires of B cells that we have investigated in this
paper, it is important to realize that these repertoires represent those B cells that
were in an activated state at the time of fusion . Earlier work (15) has shown that
activated B cells can be fused to form hybridomas at least 100 times more
successfully than resting B cells . With the assumption that every activated B cell,
at a given stage of activation, fuses equally successfully regardless of its antigen
specificity, we conclude that the hybridomas generated in these fusions, in all
likelihood, represent an average sampling of the activated B cell repertoire of
the IgM- as well as the IgG-producing cells . Furthermore, since we have plated
the originally successful fusion events at limiting dilutions,we have even excluded
a possible selection of the best-growing hybridomas from cultures with more
than one fusion event .
The transfer of Th cells of one parent into an F, host which eventually leads
to chronicGVHD and to SLE-like disease, results in a strong activation of the B
cell compartment of the host . In fact, the strength of activation by these
alloreactive Th cells appears comparable to the activation by LPS injected in
vivo . Since alloreactive T cells are potential activators of all MHC class I1-
expressing B cells in the F, host regardless of their antigen specificity, it can not
be excluded that this strong activation is, at least to a large part, polyclonal .
Activation of the B cell compartment during a secondary response to the foreign
antigen SRBC is also very strong. Only one-quarter of the B cell response appears
Autoantibodies
directed
against :
Heavy
Y3
chain
-Y1
isotypes
y2b 'y2.
Brush border - - 5 1 2
Cytoskeleton 4 1 4 2 6
Smooth muscle - - 1 1 1
Nuclei - - 2 1 7
Mitochondria - - 1 - 2
DNA 2 - 2 1 9
Undefined - - 2 1 -1684
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SRBC specific . The repertoire of binding specificities of B cells activated by
alloreactiveT cells in vivo is largely indistinguishable from that activatedby LPS
in vivo, as well as in vitro, and is also indistinguishable from the three-quarters
of the B cell response to SRBC that appears not to be SRBC specific . This
supports the notion that the early in vivo activation by alloreactive T cells, as
well as a large part of the SRBC-induced response, is polyclonal .
A transient polyclonal activation of IgM-producing cells during the first period
of the GVHR has been described (22, 23) . The kinetics of this polyclonal
activation are similar to the kinetics of the total IgM-producingB cell population
in GVHR (23) . In spite of the strong increase in IgG production, no IgG PFCs
or IgG antibodies to non-self antigens were previously found in F, with GVHD
(23, 24) . From these findings it was concluded that the autoantibody formation
in GVHD F, mice is due to the specific triggering of a certain population of
autoreactive B cells and nottoa polyclonal B cell stimulation . The data presented
here appear toargue against such specific triggering of autoreactiveB cells, since
the frequencies ofautoreactive B cellsafterstimulation by GVHR and after LPS-
induced polyclonal B cell stimulation are the same. An explanation for the
apparent absence of B cells producing IgG antibodies to non-self antigens in F,
mice with GVHD (23, 24) might be that the affinities of antibodies to non-self
antigens are so low that the antibodies are only detected in the assayas polyvalent
IgM but notas divalent IgG, a difference that may not be detected in oligoclonal
serum responses but that becomes apparent when mAbs are measured .
The spectrum of autoantibody specificities is certainly not restricted to intra-
cellular autoantigens that we tested in this paper since we have also seen
autoantibodies to cell-surface antigens (Strasser, A., manuscript in preparation) .
Thus, autoantigen-binding, Ig-secreting hybridomas are formed in all B cell
repertoires, whether experimentally unstimulated, or stimulated in vitro or in
vivo in various ways . Their frequencies within theIgM-secreting Bcell repertoires
are indistinguishable from each other . This further supports conclusions drawn
by others (1-9) that the B cell repertoire is not purged of self antigen-binding
cells . Tolerance within the B cell compartment appears not to be achieved by
clonal elimination of IgM-producing cells during B cell development, nor does
the system prevent the background activation of self antigen-binding, IgM-
producing B cells .
In marked contrast, self antigen-binding, IgG-producing B cells are not
detectable, either within the experimentally unstimulated or within the LPS- or
SRBC-stimulated repertoires . Therefore, it could be that normally the system
does notallow switchingof self antigen-reactive B cellsto IgGandhence somatic
hypermutations in such B cell clones wouldnotoccurorwould be very infrequent
events .
However, if the B cell compartment is stimulated in vivo by alloreactive T
cells, self antigen-binding, IgG-producing B cells predominate in the response .
This, then, may set the stage for somatic hypermutations and selection of the
better fitting self antigen-reactive B cell clones by self antigen . Alloreactive
parental Th cells recognizing the foreign class II MHC antigens in the F, mice
probably play a crucial role in the switch from IgM to IgG production . The roleROLINK ET AL.
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of self antigens in this process of switching to IgG, however, remains unclear
from our analyses .
The observation that thymocyte-specific antibodies are readily detectable 1 wk
after injection of alloreactive T cells, while antinuclear antibodies can only be
detected 2 wks after injection, could indicate that some self antigens might be
more efficient in selecting IgG-producing B cell clones than others, perhaps
because they are more readily available . The repertoire of self antigen-binding
specificities, however, remains largely polyclonal as theGVHD begins to manifest
itself. Therefore, no dominance of few self antigens is visible within this autoan-
tigen-binding, IgG-producing repertoire . A possibly significant exception is the
detection ofone specificity : that against a 160-kD protein in microvilli of kidney
brush borders, which we have found only in theGVHD hosts, but not in normal
repertoires (Rolink, A., manuscript submitted for publication) . In general, our
analysis of the autoantigen-binding splenic B cell repertoire ofGVHD animals
has not yet yielded any definitive clues as to whether a limited selection of
autoantigens are instrumental in the induction and/or propagation of this sys-
temic autoimmune disease . It appears worthwhile to expand these repertoire
investigations to specific sites within the body where autoimmune stimulation by
alloreactive T cellscould locally initiate and perpetuate this autoimmune disease .
Moreover, experiments aimed at defining the events that are responsible for the
switching of self antigen-binding B cells from IgM to IgG production and the
role that self antigens play in this process now appear crucial for a better
understanding of the pathogenesis of SLE-like and other autoimmune diseases .
Summary
A quantitative analysis of the frequencies of autoantibody-producing B cells in
GVHD and in normal mice has been undertaken by generating collections of
hybridomas of activated B cells. These hybridomas secreted sufficient quantities
of Ig to allow binding analyses on a panel of autoantigens . B cells have been
activated in a variety of ways . In vivo they were activated by injection of
alloreactive T cells ofone parent, leading toGVHD by a foreign antigen, sheep
erythrocytes, in a secondary response, or by the polyclonal activator LPS . B cells
from an experimentally unstimulated animal were used for an analysis of the
normal background. In vitroB cells were activated by alloreactiveT cells or by
LPS.
The frequencies of hybridomas and, therefore, of activated B cells producing
autoantibodies to DNA or to kidney were not significantly different in mice
activated by a graft-vs.-hostT cell response as compared with B cell populations
activated by any of the other procedures . They were found to compose 7.1-
17.1% of the total repertoire of activated B cells. Moreover, the frequencies of
autoantibody-producing activated B cells does not change with time after induc-
tion of the graft-vs.-host reaction . The pattern and frequencies of autoantigen-
binding specificities to cytoskeleton, smooth muscle, nuclei, mitochondria, and
DNA were not found to be different in any of the groups of hybridomas . The
single notable exception, found in GVHD mice, were hybridomas producing
autoantibodies to kidney proximal tubular brush border . These results allow the
conclusion that autoantigen-binding B cells exist in an activated state in GVHD1686
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mice, as well as in mice activated by a foreign antigen or by a polyclonal activator,
in B cell populations activated in vitro either by alloreactive T cells or by a
polyclonal activator, and even in thebackground of experimentally unstimulated
animals . T cell-mediated graft-vs.-host activation, in large part, does not lead to
a selective expansion of autoantigen-binding B cells . The main difference be-
tween the graft-vs.-host-activated B cell repertoire and all others is that ^-90%
of the autoantibodies were of the IgG class, whereas all autoantibodies found in
the other groups were IgM .
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